Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Businesswire News Releases

Apr 24, 2024 07:30 ET
Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-CFB for Treatment of Complement Mediated Kidney Disease
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) announced today that it has dosed the first subjects in a Phase 1/2a clinical trial (NCT06209177) of ARO-CFB, the company’s investigational RNA interference (RNAi) therapeutic, in up to 66 healthy volunteers and patients with complement mediated kidney disease...
Apr 24, 2024 07:30 ET
Endeavor BioMedicines Raises $132.5 Million Oversubscribed Series C Financing to Advance Pipeline of Transformational Medicines
Endeavor BioMedicines, Inc. (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, today announced the closing of a $132.5 million Series C financing, including the conversion of a $5 million convertible instrument. The oversubscribed round was led by AyurMaya, an affiliate of Matrix Capital Management, with participation from new investors including Fidelity Management & Research Company, Invus, SymBiosis, Velosity Capital, and Woodline Partners; and strong support f...
Apr 24, 2024 07:30 ET
PROG Holdings Reports First Quarter 2024 Results
PROG Holdings, Inc. (NYSE:PRG), the fintech holding company for Progressive Leasing, Vive Financial, Four Technologies, and Build, today announced financial results for the first quarter ended March 31, 2024....
Apr 24, 2024 07:30 ET
Redwire Signs MOU with Boryung to Support its Trailblazing Humans In Space Program for Global Human Health
Redwire Corporation (NYSE: RDW), a global leader in microgravity research, development, and manufacturing announced that it has signed a memorandum of understanding (MOU) with Boryung Corporation, a pioneer in innovative solutions based in Korea. Through the agreement, Redwire will serve as an implementation partner in support of Boryung’s
Apr 24, 2024 07:30 ET
Sterling Bancorp Reports First Quarter 2024 Financial Results
Sterling Bancorp, Inc. (NASDAQ: SBT) (“Sterling” or the “Company”), the holding company of Sterling Bank and Trust, F.S.B. (the “Bank”), today reported its unaudited financial results for the first quarter ended March 31, 2024....
Apr 24, 2024 07:00 ET
2024 Talent Experience Award Winners Celebrated at IAMPHENOM
Phenom today announced the 2024 Talent Experience award winners recognizing organizations’ extraordinary achievements using intelligence, automation and experience to hire, develop and retain employees....
Apr 24, 2024 07:00 ET
Airwallex Expands Payment Acceptance to the U.S., Cementing Its Position as a Leading One-Stop Financial Platform for Borderless Businesses
Airwallex, a leading global payments and financial platform for modern businesses, today announced the U.S. launch of its payment acceptance solution. U.S.-based merchants can use the service to accept payments from domestic and international customers. Additionally, foreign merchants with U.S. entities can provide a localized payment experience to thei...
Apr 24, 2024 07:00 ET
Avēsis and Harmony Health Launch Pioneering Salivary Testing Pilot for Patients with Special Healthcare Needs
Avēsis and Harmony Health have joined forces to bridge oral healthcare gaps for underserv...
Apr 24, 2024 07:00 ET
BioIntelliSense Announces Completion of Houston Methodist Inpatient Expansion of the BioButton® Continuous Patient Monitoring Solution
BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces completion of Houston Methodist’s inpatient expansion of the BioButton® continuous patient monitoring solution across all 2,653 non-ICU beds at the system’s eight hospitals. The FDA-cleared BioIntelliSense BioButton multiparameter wearable is ap...
Apr 24, 2024 07:00 ET
Blackstone Mortgage Trust Reports First Quarter 2024 Results
Blackstone Mortgage Trust, Inc. (NYSE: BXMT) today reported its first quarter 2024 results. The net loss attributable to Blackstone Mortgage Trust for the quarter was $124 million. First quarter EPS, Distributable EPS, Distributable EPS prior to charge-offs, and dividends paid per basic share were ($0.71), $0.33, $0.65, and $0.62, respectively....
Apr 24, 2024 07:00 ET
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Innoviva Specialty Therapeutics, Inc., a subsidiary of Innoviva, Inc. (NASDAQ: INVA), today announced that positive results from the Phase 3 oral zoliflodacin trial will be highlighted in an oral presentation given by the Global Antibiotic Research & Development Partnership (GARDP) at the European Society of Clinical Microbiology and Infectious Disease Global Congress (ESCMID Global 2024) taking place April 27-30, 2024, in Barcelona, Spain. Zoliflodacin is a first-in-class spiropyrimidinetrione, single dose, oral antibiotic that is being developed in partnership with GARDP for the treatment of...
Apr 24, 2024 07:00 ET
KnowBe4 to Acquire Egress
KnowBe4, the provider of the world’s largest security awareness training and simulated phishing platform, today announced it has entered into a definitive agreement to acquire Egress, a leader in adaptive and integrated cloud email security. Egress’ Intelligent Email Security suite provides a set of scaled, AI-enabled security tools with adaptive learning capabilities to help prevent, protect and defend organizations against sophisticated email cybersecurity threats. Further terms of the transaction were not disclosed....
Apr 24, 2024 07:00 ET
LCI Industries First-Quarter 2024 Conference Call Scheduled for May 8, 2024, at 8:30 a.m. ET
LCI Industries (NYSE: LCII), which, through its wholly-owned subsidiary, Lippert Components, Inc. ("Lippert"), supplies, domestically and internationally, a broad array of highly engineered components for the leading original equipment manufacturers ("OEMs") in the recreation and transportation markets, and the related aftermarkets of those industries, will release its first quarter of 2024 financial results before the market opens on Wednesday, May 8, 2024....
Apr 24, 2024 07:00 ET
Masco Corporation Reports First Quarter 2024 Results
Masco Corporation (NYSE: MAS), one of the world’s leading manufacturers of branded home improvement and building products, reported its first quarter 2024 results....
Apr 24, 2024 07:00 ET
Mr. Cooper Group Reports First Quarter 2024 Results
Mr. Cooper Group Inc. (NASDAQ: COOP) (the “Company”), reported first quarter income before income tax expense of $232 and net income of $181 million. Excluding other mark-to-market and other adjustments, the Company reported pretax operating income of $199 million. Adjustments included other mark-to-market net of hedges of $42 million and other items shown below in the reconciliation of GAAP and non-GAAP results....
Apr 24, 2024 07:00 ET
Old Dominion Freight Line Reports First Quarter 2024 Earnings Per Diluted Share of $1.34
Old Dominion Freight Line, Inc. (Nasdaq: ODFL) today announced financial results for the three-month period ended March 31, 2024....
Apr 24, 2024 07:00 ET
Performance Food Group Company to Host Webcast of Third-Quarter Fiscal 2024 Results
Performance Food Group Company (PFG) (NYSE:PFGC) will host a live audio webcast at 9 a.m. ET Wednesday, May 8, to discuss third-quarter fiscal 2024 financial results. PFG will issue a news release with those results at approximately 7 a.m. ET that same day....
Apr 24, 2024 07:00 ET
Sensata Technologies Board Approves Q2 Dividend of $0.12 Per Share
Sensata Technologies (NYSE: ST), a leading industrial technology company and provider of sensor-rich solutions and insights for customers, today announced that its Board of Directors approved a quarterly dividend in the amount of $0.12 per share. The Company will pay this second quarter 2024 dividend on May 22, 2024, to shareholders of record as of May 8, 2024....
Apr 24, 2024 07:00 ET
TotalEnergies and Vanguard Renewables, a Portfolio Company of BlackRock’s Diversified Infrastructure Business, Join Forces to Develop Renewable Natural Gas in the United States
TotalEnergies, a global integrated energy company, and Vanguard Renewables, a U.S. leader in farm-based organics-to-renewable natural gas production and a portfolio company of a fund managed by BlackRock’s Diversified Infrastructure business, have signed an agreement to create an equally owned joint venture to develop, build, and operate Farm Powered® renewable natural gas (RNG) projects in the United States. The signing took place in New York on April 12th 2024 in the presence of Patrick Pouyanné, Chairman and CEO of TotalEnergies and Larry Fink, Chairman and CEO of Blac...
Apr 24, 2024 07:00 ET
United Therapeutics Corporation to Report First Quarter 2024 Financial Results Before the Market Opens on Wednesday, May 1, 2024
United Therapeutics Corporation (Nasdaq: UTHR), announced today that it will report its first quarter 2024 financial results before the market opens on Wednesday, May 1, 2024. A press release detailing the quarterly results will be issued that day at approximately 6:30 a.m. Eastern Time....